Use Of Green Porphyrinsto Treat Neovasculature In The Eyes

Patent · 25 August 1998

OSTI ID:879252

Levy, Julia ^[1]; Miller, Joan W ^[2]; Gradoudas, Evangelos S ^[2]; Hasan, Tayyaba ^[3]; Schmidt-Erfurth, Ursula ^[4]

---

1. Vancouver, CA
2. Boston, MA
3. Arlington, MA
4. Luebeck, DE

Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.

• Research Organization: Massachusetts General Hospital
• DOE Contract Number: FG02-91ER61228
• Assignee: The General Hospital Corporation (Boston, MA); Quadra Logic Technologies, Inc. (Vancouver, B.C., CA); Massachuesetts Eye & Ear Infirmary (Boston, MA)
• Patent Number(s): US 5798349
• Application Number: 08/390591
• OSTI ID: 879252
• Country of Publication: United States
• Language: English